Skip to main content
Clinical Trials/CTRI/2019/05/018911
CTRI/2019/05/018911Active, not recruitingPhase 2

Study of Prevalence of Iron Deficiency Anemia in Children and Efficacy of Drakshadi Leha in its Management

ational Institute of Ayurveda0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Active, not recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Subjects aged between 6-12 years
  • 2. Subjects with iron deficiency anemia (Hb. 7 gm% -11.9 gm %).
  • 3. Subjects whose parents are willing to give consent for clinical trial.

Exclusion Criteria

  • 1. Hemoglobin <7gm/dl.
  • 2. Subjects suffering from major systemic illness necessitating long term treatment.
  • 3. Subjects with evidence of malignancy.
  • 4. Subjects with concurrent serious hepatic dysfunction (defined as AST and/or ALT >3 times of the upper normal limit) or renal dysfunction (defined as S. creatinine >1.2mg/dl), uncontrolled pulmonary dysfunction (asthmatic and COPD patients)
  • 5. Co-morbidity like TB, UTI and bleeding disorders etc.
  • 6. H/o hypersensitivity to any of the trial drug or their ingredients.
  • 7. Subjects who have completed participation in any other clinical trial during the past six months.

Investigators

Similar Trials

To evaluate the clinical efficacy of an... | Clinical Trial